Rezultati

eNauka >  Results >  An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC.
Title: An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC.
Authors : Kim, Tae Won; ...; (broj, koautora 16)
Issue Date: 2016
Publication: JOURNAL OF CLINICAL ONCOLOGY
ISSN: 0732-183X Journal of Clinical Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 34 br. 4 str. 642-642
DOI: 10.1200/jco.2016.34.4_suppl.642
WoS-ID: 000378109600618
URI: https://enauka.gov.rs/handle/123456789/820957
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

2
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.